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OBJECTIVE—Lipotoxicity and ectopic fat deposition reduce
insulin signaling. It is not clear whether excess fat deposition in
nonadipose tissue arises from excessive fatty acid delivery from
adipose tissue or from impaired adipose tissue storage of in-
gested fat.
RESEARCH DESIGN AND METHODS—To investigate this
we used a whole-body integrative physiological approach with
multiple and simultaneous stable-isotope fatty acid tracers to
assess delivery and transport of endogenous and exogenous fatty
acid in adipose tissue over a diurnal cycle in lean (n  9) and
abdominally obese men (n  10).
RESULTS—Abdominally obese men had substantially (2.5-fold)
greater adipose tissue mass than lean control subjects, but the
rates of delivery of nonesteriﬁed fatty acids (NEFA) were down-
regulated, resulting in normal systemic NEFA concentrations
over a 24-h period. However, adipose tissue fat storage after
meals was substantially depressed in the obese men. This was
especially so for chylomicron-derived fatty acids, representing
the direct storage pathway for dietary fat. Adipose tissue from
the obese men showed a transcriptional signature consistent
with this impaired fat storage function.
CONCLUSIONS—Enlargement of adipose tissue mass leads to
an appropriate downregulation of systemic NEFA delivery with
maintained plasma NEFA concentrations. However the implicit
reduction in adipose tissue fatty acid uptake goes beyond this
and shows a maladaptive response with a severely impaired
pathway for direct dietary fat storage. This adipose tissue
response to obesity may provide the pathophysiological basis for
ectopic fat deposition and lipotoxicity. Diabetes 60:47–55,
2011
T
he metabolic function of adipose tissue is fat
storage. An expansion of adipose tissue mass, in
particular abdominal obesity, is associated with
an increased risk of type 2 diabetes (1), cardio-
vascular disease (2), insulin resistance (3), and all-cause
mortality (4,5). It is postulated that adipose tissue acts to
“buffer” the inﬂux of dietary fat into the circulation (6,7).
Thus excess dietary fat should be stored in adipose tissue
and not “overﬂow” to other organs such as the liver and
skeletal muscle. Inappropriately stored fat in nonadipose
tissue, ectopic fat deposition, has been proposed to under-
lie obesity-associated insulin resistance (8). Therefore the
more efﬁcient the regulation of fat storage in adipose
tissue, the less the lipotoxic effects on nonadipose tissues.
The release of nonesteriﬁed fatty acids (NEFAs) from
upper-body subcutaneous adipose tissue is a major deter-
minant of systemic NEFA plasma concentrations (9),
whereas visceral fat may contribute fatty acids speciﬁcally
to the liver. Increased fasting concentrations of NEFA
have been related to adipose tissue mass (10) and the
presence of type 2 diabetes (11). However complete
absence of such relationships has also been described in
nondiabetic people (12–14). After a single meal, the post-
prandial concentrations of NEFA tend to remain some-
what higher in obese compared with lean people (15,16).
Although adipose tissue masses may vary over a 10-fold
range between people, reported fasting NEFA concentra-
tions typically only vary within a 2-fold range. This clearly
implies a restriction in the release of NEFA from the
adipose tissue of obese individuals. Although the detailed
mechanism for this restriction is unknown, it has been
observed that adipocytes isolated from overweight sub-
jects respond subnormally to adrenergic lipolytic stimula-
tion (17). However it is less clear if uptake mechanisms of
fatty acids by adipose tissue are balanced by similar
regulatory mechanisms. In the postprandial period, insulin
stimulates fat deposition into adipose tissue. This occurs
by hydrolysis of chylomicron triglycerides (TGs) by li-
poprotein lipase (LPL) bound to capillary endothelium and
subsequent uptake of the released fatty acids by adipose
tissue and reesteriﬁcation (storage). Following ingestion
of a single mixed meal, impaired postprandial plasma TG
clearance by adipose tissue was reported in obese subjects
(18). This is partly explained by a lower functional LPL
activity per unit fat mass in combination with the absence
of postprandial upregulation of adipose tissue LPL in
obesity (19). A pertinent question is therefore if adipose
tissue in obese people, despite its enlargement, will induce
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ciently as in lean people (20).
In line with the known downregulation of lipolysis in
obesity (17) and the absence of upregulation of adipose
tissue LPL activity (19), we hypothesize that individuals
with increased adiposity fail to appropriately upregulate
meal-fat storage. Therefore we investigated the impact of
obesity on systemic NEFA concentrations and NEFA
delivery from adipose tissue, and then did detailed tissue-
speciﬁc investigation of adipose tissue fatty acid trafﬁck-
ing of endogenous and meal-derived fatty acid over a 24-h
period using stable isotope tracer methodology along with
transcriptional proﬁles of the fatty acid trafﬁcking
pathways.
RESEARCH DESIGN AND METHODS
Background population. The Oxford Biobank (21) is a population-based
collection of healthy men and women between 30 and 53 years of age (n 
1,900) that was used for the recruitment of participants. We analyzed fasting
plasma TG; NEFA; insulin and glucose concentrations in male subjects within
two BMI ranges, 19–25 kg/m
2 (lean) and 27–32 kg/m
2 (abdominally obese);
and age range 30–53 years (background cohort for the tissue-speciﬁc inves-
tigation). We excluded subjects with fasting hyperglycemia (6.1 mmol/l) and
overt hypertriglyceridemia (3.0 mmol/l). Fat mass was calculated from
bioelectric impedance. Subcutaneous adipose tissue biopsies are available
from 160 of the participants in the Oxford Biobank, and we selected one lean
group (n  10, BMI 23.4  0.3 kg/m
2) and one obese group (n  10, BMI
33.6  1.7 kg/m
2) of men for studies of quantitative mRNA content of genes
involved in fatty acid trafﬁcking.
Participants in the tissue-speciﬁc investigation. Nine lean and ten
abdominally obese males, comparable for age, were randomly invited from the
Oxford Biobank (see above [n  14]) or recruited locally from Oxford after
self-reporting to advertisements (n  5). Some data from eight of the lean
males have been recently reported (20). All volunteers recruited were healthy
nonsmokers, not on any medication known to affect lipid metabolism, and
fulﬁlled the above inclusion criteria. We also required the obese participants
to have a waist circumference 99 cm. The study was approved by the
Oxfordshire Clinical Research Ethics Committee, and all subjects gave written
informed consent.
Study protocol. Subjects arrived to the clinical research unit, having fasted
from 10:00 P.M. the night before. They were asked to refrain from strenuous
exercise and alcohol for 24 h before the study.
Subcutaneous abdominal adipose tissue metabolism and blood ﬂow was
investigated by arterio-venous blood sampling as previously described (20). A
constant infusion of [
2H2]palmitate (Cambridge Isotopes, CK Gas Products,
Cambridge, UK) was given intravenously (0.01 mol/kg/min) in a total volume
of 400 ml human albumin (4.5%) over the 24 h. The infusion was started more
than 60 min before the ﬁrst blood sample.
Meals were given at time points breakfast (0), lunch (5 h), and dinner (10
h). The quantity of food was adjusted to individual basic metabolic rate (BMR)
estimated by bioimpedance (1.25  basic metabolic rate) and divided by three
to give the number of calories in each meal. Food items were weighed to the
nearest gram. Breakfast was tagged with 100 mg [U-
13C]linoleic acid, and
lunch and dinner were tagged with 100 mg [U-
13C]oleic and [U-
13C]palmitic
acid, respectively. Over the 24-h period, there were 29 blood sampling time
points with simultaneous sampling from arterial and adipose venous sites.
Further details on the administration, methodology, and calculation using the
fatty acid stable isotope tracer as well as the biochemistry methods are essentially
identical to a recent report (20) and also provided in the online appendix
(available at http://diabetes.diabetesjournals.org/cgi/content/full/db10-0867/DC1).
Adipose tissue mRNA quantiﬁcation. After local anesthesia with 1%
lignocaine, adipose tissue biopsies were taken from subcutaneous abdominal
depots using a 12-gauge needle in the fasted state. Tissue samples were
immediately extracted using TrizolR reagent (GIBCO-Life Technologies,
Grand Island, NY). Between 0.5 and 1 g of RNA were reverse transcribed to
cDNA using random hexamer primers and Invitrogen SuperScript III First-
Strand Synthesis System (Invitrogen, Carlsbad, CA). For the real-time quan-
titative PCR analyses, 4.5 l of 1 in 100 or 1 in 20 dilution of cDNA per reaction
were used in a ﬁnal reaction volume of 10 l. Seventeen genes were analyzed
(ANGPTL4, LPL, GPIHBP1, CD36, ACLS1, AGPAT9, GPAM, DGAT1, DGAT2,
HSL, PLIN, ATGL, ADBR2, LEP, CD68, CD11b, and CD163) using prede-
signed TaqMan Assays-on-Demand (Applied Biosystems, Foster City, CA)
using the ABI PRISM 7900HT Sequence Detection System (Applied Biosys-
tems). All the samples were analyzed in quadruplicate and normalized to PPIA
and RPLP0.
RESULTS
Relationship between fat mass and NEFA concentra-
tion in the population. We ﬁrst studied the relationship
between fasting plasma NEFA concentrations and fat
mass in the background population of 244 lean (BMI 19–25
kg/m
2) and 210 abdominally obese (27–32 kg/m
2) subjects
from the Oxford Biobank (21). Despite an almost twofold
difference in total body fat mass between the groups, there
was no difference in systemic NEFA concentrations (Table
1). However, compared with the lean group, the abdomi-
nally obese men showed the expected higher fasting
plasma TG, glucose and insulin concentrations, and lower
HDL cholesterol concentration.
Effect of fat mass on expression of genes involved in
adipose tissue fatty acid trafﬁcking. Of 12 selected
candidate mRNA for key points in the regulation of fatty
acid trafﬁcking genes, 11 were signiﬁcantly downregulated
in the adipose tissue of obese men with the exception of
CD36 (Supplementary Table 1). To conﬁrm that the rather
uniform downregulation of genes involved in fatty acid
trafﬁcking was not part of a universal effect brought about
by obesity, we also analyzed leptin (LEP) and CD68
mRNA, CD163, and CD11b as possible positive controls.
The expression of the latter three mark macrophage
inﬁltration in adipose tissue and are expected to be
increased in obese subjects. All macrophage markers were
increased (66–98%) (P  0.01 to P  0.001) whereas LEP
was unchanged (4%, not signiﬁcant). These ﬁndings
suggest a coordinated downregulation of genes involving
fatty acid trafﬁcking in the adipose tissue of abdominally
obese men.
Fatty acid trafﬁcking
Subject characteristics. As in the background popula-
tion, there was no difference in fasting NEFA concentra-
tions between the lean (n  9) and the abdominally obese
(n  10) group with expected differences in fasting lipids
and lipoproteins for the degree of obesity. Total fat mass
was 2.5 times higher in the abdominally obese group
(Table 1). There were clear signs of insulin resistance in
the abdominally obese group; fasting insulin was in-
creased despite near-identical fasting blood glucose be-
tween the groups (Table 1). Obese men had slightly higher
alanine aminotransferase (P  0.05), which could be an
indicator of increased liver fat. We have recently reported
on liver fatty acid partitioning in these groups of people
(22).
Diurnal plasma concentrations of TG, NEFA, glucose,
and insulin. In order to observe diurnal metabolic pat-
terns using a physiologically relevant situation, the partic-
ipants were given three standardized meals and each was
separated by 5 h. The signiﬁcant differences in fasting TG
and insulin between the groups were postprandially aug-
mented (Table 1 and Fig. 1B and D), but the postprandial
glucose concentrations were similar between the groups
(Fig. 1C). As each meal was labeled with an isotopically
labeled fatty acid, the plasma concentration of [
13C]-TG
reﬂected the chylomicron/chylomicron remnant TG con-
centrations; these were marginally higher in the abdomi-
nally obese males compared with the lean males (P  0.08,
area under curve [AUC] for the 5-h period after each meal
intake, repeated-measures ANOVA).
There were small differences in the postprandial NEFA
concentrations (Fig. 1A) between the groups. Both groups
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diately after the ﬁrst meal, but the abdominally obese group
remained 100 mol/l higher than the lean group within the
ﬁrst meal period (40 min to 240 min, P0.05 to P0.003
for the six consecutive time points measured). However,
after this there were no statistically signiﬁcant differences
between the groups over the entire 24-h period. Neither of
the groups started to return toward the initial high fasting
NEFA concentrations until the early morning.
Rate of appearance of NEFA in the systemic circula-
tion. The diurnal NEFA delivery curves were essentially
parallel between the groups. Although the fasting rate
(790  100 [lean] vs. 970  130 mol/min [abdominally
obese]) was not statistically different between the groups,
the time-averaged diurnal effect was very clear (450  35
vs. 650  50 mol/min, P  0.009) (Fig. 2A). Both groups
showed an immediate reduction in NEFA delivery in
response to the breakfast: the NEFA delivery was reduced
by 38  6% (P  0.002) in the lean group with a less
distinct response in the abdominally obese group (	19 
10%, P  0.046). Expressed as NEFA disappearance per
unit of lean body mass, the difference between the groups
disappeared (Fig. 2B). The rationale behind this is based
on the assumption that NEFA delivery equals NEFA
catabolism and that lean body mass is proportional to the
skeletal muscle and the liver. However, normalizing the
NEFA delivery to fat mass, the abdominally obese group
showed markedly lower fasting as well as time-averaged
diurnal NEFA delivery compared with the lean group (Fig.
2C). This highlights the downregulation of NEFA delivery
from the expanded adipose tissue in the abdominally
obese state.
Adipose tissue blood ﬂow. The abdominally obese men
had a profoundly suppressed baseline adipose tissue blood
ﬂow (ATBF) compared with the lean men (2.9  0.5 vs.
6.3  1.5 ml  100 g
	1  min
	1, respectively, P  0.01) and
also displayed an unresponsive postprandial ATBF regu-
lation after meal intake (Fig. 3A).
Adipose tissue fatty acid trafﬁcking. To more precisely
deﬁne the fatty acid trafﬁcking in subcutaneous adipose
tissue, we established arterio-venous blood sampling to-
gether with the ATBF measurements. In line with the
NEFA Ra per unit fat mass, the abdominally obese males
had signiﬁcantly lower abdominal subcutaneous adipose
tissue NEFA release, expressed per 100 g tissue, in the
fasting state (P  0.008) and across the second and third
postprandial periods (P  0.015) (Fig. 3B), thus conﬁrming
the systemic measurements (NEFA Ra normalized for fat
mass). The fasting NEFA Ra normalized to fat mass was
correlated with net abdominal subcutaneous adipose tis-
sue NEFA release (r  0.68, P  0.001, n  19).
Having established the quiescence in lipolytic function
in the abdominally obese adipose tissue, we focused on
fatty acid uptake by the tissue with the hypothesis that this
function would be equally suppressed. Fasting and post-
prandial removal of TG from blood across adipose tissue
reﬂects LPL rate of action. A lower fasting absolute TG
extraction across adipose tissue was observed in the
abdominally obese males compared with the lean males
(64  19 vs. 138  34 nmol  100 g
	1  min
	1, respectively,
P  0.07) (Fig. 3C). Postprandially, the abdominally obese
males had an accentuated lower TG extraction (P  0.001
for all meal periods) (Fig. 3C). While postprandial adipose
tissue TG extraction increased with each meal in lean
males (AUC 360  109, 580  173, 633  114 mol/100 g,
ﬁrst to third meal, respectively, P  0.03), it remained
unchanged in the abdominally obese males (AUC 122 
30, 164  47, 142  31 mol/100 g, ﬁrst to third meal,
respectively, P  0.18). The differences between the
groups were further augmented when the extraction of TG
carried in chylomicrons/chylomicron remnants were stud-
ied: the absolute extraction of [
13C]-TG across adipose
tissue for all the meals was considerably lower per unit
tissue in the abdominally obese males compared with the
lean males (P  0.01) (Fig. 3E and F).
As a signiﬁcant proportion of the plasma TG is carried
TABLE 1
Age, anthropometric, and biochemical characteristics of participants in the study
Background population identiﬁed
from the Oxford Biobank
Adipose tissue fatty acid trafﬁcking
study
Lean males
Abdominally
obese Lean males
Abdominally
obese
n 244 210 9 10
Age (years) 41  64 2  53 7  11 42  7
BMI (kg/m
2) 23.1  1.3 29.0  1.4*** 22.3  1.9 30.8  2.9***
Waist circumference (cm) 84  6 100  6*** 81  4 108  7***
Fat mass (kg) 14.3  2.3 25.1  3.6*** 10.8  3.0 25.0  6.4***
Basal metabolic rate (kcal/day) n/a n/a 1,780  200 2,140  220**
Fasting lipids, insulin, and glucose
Total cholesterol (mmol/l) 5.3  0.9 5.7  1.0*** 4.0  1.2 4.7  1.2
HDL cholesterol (mmol/l) 1.3  0.3 1.1  0.2*** 1.1  0.3 1.0  0.1
Triglyceride (mmol/l) 1.1  0.5 1.6  0.6*** 0.9  0.3 1.2  0.3*
Nonesterifed fatty acids (mol/l) 473  259 449  197 599  154 568  137
Glucose (mmol/l) 5.2  0.4 5.3  0.4** 5.2  0.4 5.2  0.3
Insulin (pmol/l) 46  20 67  29*** 55  88 0  36*
Time-averaged postprandial plasma
concentrations
Triglyceride (mmol/l) 1.1  0.3 1.6  0.3**
Insulin (pmol/l) 122  28 210  73**
Glucose (mmol/l) 5.9  0.6 6.1  1.2
NEFA (mol/l) 283  57 309  36
Values are mean  SD *P  0.05, **P  0.01, ***P  0.001 comparing abdominally obese and lean groups. n/a, not applicable.
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by making use of the [
2H2]palmitate accumulation in the
whole plasma TG, which represents newly synthesized
VLDL. The [
2H2]palmitate-TG in plasma rose to a plateau
concentration after 150 min with distinctly higher concen-
trations in the abdominally obese group compared with
the lean group (2.1  0.3 vs. 0.9  0.1 mol/l, P  0.003)
(Supplementary Fig. 1). The fractional extraction of
[
2H2]palmitate-TG across adipose tissue was similar be-
tween the groups (10.0  1.5 vs. 13.3  1.7%, not signiﬁ-
cant, average of the time period 150–900 min) despite
the considerably higher arterial concentration of
[
2H2]palmitate-TG. These data demonstrate a downregula-
tion of the efﬁciency of the uptake of fatty acid from all
triglyceride-rich lipoproteins in obese adipose tissue. It
was therefore also pertinent to note that the glucose
uptake by adipose tissue was much lower in the abdomi-
nally obese men compared with the lean men as a sign of
generally lower metabolic substrate utilization (Fig. 3D).
The arterio-venous model allowed us to study the net
movement of fatty acid across the tissue bed, the trans-
capillary ﬂux of fatty acid (23). In the fasting state, the net
movement of fatty acids was directed from adipose tissue
to the capillaries and was lower in the abdominally obese
males compared with the lean males (	700  210 vs.
	2,950  860 nmol  100 g
	1  min
	1, respectively, P 
0.06). In both groups, the direction soon changed after the
ﬁrst meal, and there was net deposition of fatty acids into
adipose tissue (Fig. 4A).
In the lean men, there was a threefold increase in
transcapillary ﬂux of fatty acids in response to sequential
meal intake (comparison of ﬁrst to third meal, Fig. 4A). In
the abdominally obese males, the transcapillary ﬂux of
fatty acids was overall much lower (AUC for 5-h postpran-
dial periods P  0.026) and less dynamic with no increase
in transcapillary ﬂux with meal sequence (Fig. 4A). These
ﬁndings were corroborated by studying the transcapillary
ﬂux of all [
2H2]palmitate-fatty acid (composite measure-
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FIG. 1. Arterial plasma concentrations of NEFA (A), TG (B), glucose (C), and insulin (D) in lean males (F) and abdominally obese males (E).
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latter is the minor component [24]). This also showed a
lower and nondynamic ﬂux of fatty acids in the adipose
tissue in the abdominally obese individuals compared with
the lean individuals (P  0.04, RM-ANOVA, Fig. 4B).
A proportion of fatty acid released by LPL escape
reesteriﬁcation, and this pathway has been denoted “spill-
over” (25), which could make a contribution to the sys-
temic NEFA concentrations (26). We therefore explored
the quantitative signiﬁcance of this pathway. In lean males,
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13C]-fatty acid, repre-
senting dietary-derived fat) spillover fraction decreased
progressively across meal periods as determined at the
end of each postprandial period (65, 48, and 37%, ﬁrst to
third meal, P  0.006) (Supplementary Fig. 2A). However,
in the abdominally obese males, it remained unchanged
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3b y ) in lean men (E) and in abdominally obese men (F) shows a diminution (P < 0.01) of
13C-TG extraction in the abdominally obese men in
line with the net TG extraction (C). AT, adipose tissue.
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(35, 24, and 24%, ﬁrst to third meal, P  0.13) (Supplemen-
tary Fig. 2B). We then calculated the relative proportion of
the systemic NEFA concentration that originated from
spillover from the chylomicron-carried dietary fat. This
shows that the proportion of NEFA derived from adipose
tissue spillover is consistently lower (P  0.01) in the
abdominally obese men than their lean counterparts over
the meal-feeding period (Supplementary Fig. 2C).
Estimations of whole-body fatty acid deposition into
adipose tissue. It is of importance to consider the ex-
panded adipose tissue mass at the whole-body level in the
abdominally obese individuals to understand the adapta-
tion of the system. In the calculation of whole-body effects,
we assume that all adipose tissues have similar handling of
fatty acid. Thus, accounting for total body fat mass, it was
clear that the abdominally obese males had lower total
adipose tissue TG extraction compared with the lean men.
Over the three consecutive meal periods, they had pro-
gressively lower total adipose tissue TG extraction: over
the third meal period (meal period AUC data from Fig. 3C
multiplied by fat mass), the abdominally obese men’s
adipose tissue extracted only 53% (P  0.01) of what was
seen in the lean men. The difference between the groups
was further ampliﬁed when the same calculation was
applied to the transcapillary ﬂux of fatty acids (net fat
storage) from the abdominal subcutaneous adipose tissue
depot. Over the third meal period (meal period AUC data
from Fig. 4A multiplied by fat mass), the abdominally
obese men stored only 43% of the fat in adipose tissue
compared with the lean men (P  0.03). As previously
mentioned, the adipose tissue fatty acid uptake from
chylomicrons was particularly low in the abdominally
obese men compared with the lean men, whereas the fatty
acid uptake from VLDL was less affected (the fractional
extraction was similar between the groups, yet the con-
centration was higher in the abdominally obese men). The
total AUC of the transcapillary ﬂux of [
2H2]-palmitate
(dominated by the [
2H2]-palmitate carried by TG in VLDL)
factored up for fat mass was twice as high in the abdom-
inally obese men compared with the lean men (178  50
vs. 73  14 mol/h, P  0.049) (calculated from Fig. 4B).
This implies that a higher proportion of the fatty acid
stored in adipose tissue originates from VLDL-TG in ab-
dominally obese men compared with lean men. However
for glucose uptake by adipose tissue, the differences
between groups disappeared when accounting for total fat
mass, and net glucose disposal through adipose tissue is
likely to be similar between lean and obese people.
In order to estimate the relative quantity of the meal fat
that was stored in adipose tissue, the fat content of each
meal was divided by the calculated whole-body net fat
storage during the three consecutive 5-h meal periods. In
lean males, there was progressive increase in the deposi-
tion of meal fat into adipose tissue with each meal (13, 35,
and 47%, ﬁrst to third meal, respectively, P  0.001) (Fig.
4C). In contrast, the abdominally obese males failed to
increase fat storage with sequential feeding (6, 25, and
18%, ﬁrst to third meal, respectively, P  0.12) (Fig. 4C).
This difference was highly statistically signiﬁcant for the
last meal period (P  0.001).
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FIG. 4. Total transcapillary ﬂux of fatty acids across adipose tissue (A)
in lean (F) and abdominally obese (E) men following ingestion of three
meals (as indicated by the dotted vertical lines). B shows the trans-
capillary ﬂux of [
2H2]-palmitate, which is dominated by the label
carried in [
2H2]-TG (VLDL). C shows the percentage of meal fat content
deposited in adipose tissue after three sequential meals (meal 1, meal
2, meal 3) in lean (f) and abdominally obese () males. This was
calculated from the transcapillary ﬂux (A) where each 5-h time period
(AUC) multiplied for body fat mass to arrive at total body fat being
stored. The denominator for each time period is the fat content in the
meal. Lean men show a signiﬁcant meal  fractional uptake effect (P 
0.009), whereas the effect is statistically nonsigniﬁcant in the abdom-
inally obese men. AT, adipose tissue.
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Upper-body subcutaneous adipose tissue is the main site
of storage and release of fatty acid to the systemic
circulation (27) and by comparing lean healthy men with
moderately abdominally obese men, we describe a re-
markable adaptation of the expanded adipose tissue. In
terms of delivery of NEFA from the tissue, this adaptation
appears to be entirely appropriate, resulting in normal
diurnal regulation of NEFA concentrations in abdominally
obese men, which is brought about by signiﬁcantly dimin-
ished NEFA release rates per unit of adipose tissue. The
storage of fatty acids from plasma TG was correspond-
ingly reduced in subjects with abdominal obesity and in
this pathway there were also a clear signs of maladapta-
tion; there was an inability to induce fat storage with
sequential meals combined with a failure to effectively
store the chylomicron-TG–derived fatty acids originating
from the most recent meal. We propose that this is the
pathophysiological basis for diversion of fatty acid to be
stored in organs not dedicated for fat storage, i.e., ectopic
fat deposition.
One such organ is the liver and, in the loops of fatty acid
trafﬁcking studied in this article, this became very clear. In
lean men, a high proportion of chylomicron-TG was stored
immediately in adipose tissue, whereas a lower proportion
was seen in abdominally obese men. In contrast, fatty acid
originating from VLDL-TG appeared to play a greater
proportional role in adipose tissue fat storage in the
abdominally obese men. These events are linked, as insuf-
ﬁcient extraction of chylomicron-TG produce chylomicron
remnants, the TG content of which will be deposited in the
liver and thereby provide substrate for VLDL-TG produc-
tion. The liver in abdominally obese men is therefore
burdened by this seemingly “unnecessary” loop of fatty
acid trafﬁcking and also showed slightly higher plasma
alanine aminotransferase concentrations as an indicator of
increased liver fat content.
Obese subjects are often reported to have higher fasting
and postprandial NEFA concentrations than lean subjects
(10,28), which is thought to be due to the expansion of fat
mass (29). However the diurnal systemic NEFA concen-
trations were essentially not different between lean and
abdominally obese males. Although the suppression of
systemic NEFA concentrations after the ﬁrst meal was less
marked in the abdominally obese group, which is in line
with the observations made by others (16), this was a
negligible difference over the 24-h period. Also the fasting
concentration of NEFA of much larger numbers of ran-
domly recruited lean and abdominally obese people were
not different from each other. As this observation is made
in moderate stages of obesity in seemingly healthy indi-
viduals, it suggests that NEFA oversupply to the systemic
circulation might not be an early or universal feature of the
metabolic complications of obesity. Not only does this
ﬁnding concur with studies of BMI-matched insulin-resis-
tant and insulin-sensitive men (14), but it also concurs
with a more extreme example of obesity (13). They are
also in line with a recent study by Mittendorfer et al. (12),
which describes a similar, but not complete, downregula-
tion of NEFA Ra in a group exhibiting a very wide range of
body fat content. It is also noted that very large-scale
observations in the Paris Prospective Study (30) showed no
association between BMI and fasting NEFA concentrations.
Given the similar systemic NEFA concentrations be-
tween the groups in this study, despite a 2- to 2.5-fold
difference in the whole-body adipose tissue mass, we
interrogated in detail the mechanisms of NEFA delivery
from the tissue. In line with earlier observations for LPL
(31) and hormone-sensitive lipase (HSL) and adipose
triglyceride lipase (ATGL) (32), we found lower expres-
sion in obese/insulin-resistant men, but our ﬁndings on
transcript regulation also indicate a profound lowering of
all processes involved in fatty acid trafﬁcking in obesity.
Most NEFAs delivered from adipose tissue originate from
intracellular TG via ATGL/HSL-mediated lipolysis. How-
ever, a smaller proportion is originating from spillover of
fatty acid derived from the LPL-mediated lipolysis of
chylomicron and VLDL-TG and subsequently failing to
undergo reesteriﬁcation. The spillover was generally lower
and certainly less dynamic in the abdominally obese
group, observed both locally in the adipose tissue after
each meal as well as its relative contribution to the
systemic NEFA concentration. As the overall quantity of
LPL-mediated fatty acid delivery to the tissue was much
smaller in the abdominally obese group, we conclude that
once fatty acid has been generated through this pathway,
they appear to be readily reesteriﬁed. Accordingly, the
reesteriﬁcation pathway does not seem to be subject to the
same degree of downregulation as the LPL step in obese
adipose tissue.
A limitation of this study is the extrapolation of whole-
body fat storage from the local measurement in the
abdominal subcutaneous tissue knowing that fat depots
have different characteristics in this respect. However,
from the point of view of NEFA delivery from adipose
tissue to the systemic circulation, this extrapolation has
validity as the signiﬁcant majority of NEFAs delivered to
the systemic circulation originates from this depot (27).
However, with the same argument, we ﬁnd it difﬁcult to
raise support for the argument that excessive NEFA
delivery from adipose tissue to the systemic circulation is
an early determinant of the insulin resistance in obesity.
We have only studied men; extrapolations to women
cannot be made.
In summary, adipose tissue shows appropriate adapta-
tion to obesity in terms of systemic NEFA delivery, and
this is part of a global response (silencing of metabolic and
vascular functions of the tissue), whereas the correspond-
ing downregulation of fat storage exhibit a maladaptive
response with insufﬁcient sequestration of dietary fatty
acid that may trigger ectopic fat deposition.
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